Gene Therapy: A Battle Against Biological Barriers

Author: Kaneda Y.

Source: Current Molecular Medicine, Volume 1, Number 4, September 2001 , pp. 493-499(6)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

One factor critical to successful human gene therapy is development of efficient gene delivery systems. Although numerous vector systems for gene transfer have been developed, a perfect vector system has not yet been constructed. Difficulties of in vivo gene transfer appear to result from resistance of living cells to invasion by foreign materials and from interference of cellular functions. We should analyze what barriers in tissues affect in vivo gene transfection and how to solve these problems for gene therapy. In this review article, the biological barriers to in vivo gene transfection are discussed and possible solutions to each barrier are discussed with respect to construction of a perfect gene therapy vector system.

Keywords: vascular endothelial growth factor (VEGF); combined immunodeficiency; Retrovirus vecto; Adenovirus vector; Adeno-associated virus vector; Liposome DNA complex

Language: English

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1566524013363519

Publication date: 2001-09-01

More about this publication?

Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal will invite guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.